Back to top

Jefferies continues to like Teva after recent pullback

Noting that Teva (TEVA) has underperformed the last two weeks, Jefferies analyst Dennis Ding explained that a “big part of the weakness is due to m...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Teva Pharmaceutical Industries Ltd. (TEVA)